Positive allosteric modulator of the GABA-A receptor counteracts hepatic fibrosis with profound anti-obesity action
Elisabeth Rohbeck(Deutsches Diabetes-Zentrum e.V.), Juergen Eckel, D. Margriet Ouwens(Leiden University Medical Center), Corinna Niersmann, Karl-Erich Köhrer, Volker M. Lauschke(Karolinska University Hospital), Michael Roden, Bedair Dewidar(Tanta University), Thorsen Wachtmeister, Bruno Guigas(Leiden University Medical Center)
Cited by 0
Related Papers
<scp>TGF</scp>‐β signalling and liver disease
|FEBS Journal|2016|611
Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats
|Diabetologia|2005|254
Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38
|The EMBO Journal|2002|226
Metabolic liver disease in diabetes – From mechanisms to clinical trials
|Metabolism|2020|156